|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Cystic Tumors of the Pancreas | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Pancreatic Neoplasms | |||||
| 3 | More general conditions related to this trial | ||||
| Digestive System Diseases | |||||
| Digestive System Neoplasms | |||||
| Endocrine Gland Neoplasms | |||||
| Endocrine System Diseases | |||||
| Neoplasms | |||||
| Neoplasms by Site | |||||
| Pancreatic Diseases | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Ethanol | |||||
| Paclitaxel | |||||
| Pancrelipase | |||||
| 5 | More general drug interventions related to this trial | ||||
| Anti-Infective Agents | |||||
| Anti-Infective Agents, Local | |||||
| Antimitotic Agents | |||||
| Antineoplastic Agents | |||||
| Antineoplastic Agents, Phytogenic | |||||
| Central Nervous System Agents | |||||
| Central Nervous System Depressants | |||||
| Gastrointestinal Agents | |||||
| Mitosis Modulators | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| Tubulin Modulators | |||||
| 6 | Sponsors listed in this trial | ||||
| Asan Medical Center | |||||